Compare LEXX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | ASBP |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 11.3M |
| IPO Year | 2011 | 2021 |
| Metric | LEXX | ASBP |
|---|---|---|
| Price | $4.53 | $8.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 32.2K | 24.8K |
| Earning Date | 11-27-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $705,923.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,915.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.35 | $3.31 |
| 52 Week High | $21.60 | $367.50 |
| Indicator | LEXX | ASBP |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 54.13 |
| Support Level | $2.67 | $7.65 |
| Resistance Level | $10.26 | $9.24 |
| Average True Range (ATR) | 0.41 | 0.62 |
| MACD | 0.19 | 0.09 |
| Stochastic Oscillator | 74.74 | 79.10 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain-agnostic product portfolio that includes mechatronic actuators, human-machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates around 11 manufacturing facilities globally and serves as a tier-one automotive supplier to OEMs and other industrial firms.